Citations (80)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (15)
Lingbin Zeng. (2016) Mucosal adjuvants: Opportunities and challenges. Human Vaccines & Immunotherapeutics 12:9, pages 2456-2458.
Read now
Read now
Sang-Moo Kang, Jae-Min Song & Yeu-Chun Kim. (2012) Microneedle and mucosal delivery of influenza vaccines. Expert Review of Vaccines 11:5, pages 547-560.
Read now
Read now
Amit A. Lugade, Suresh Kalathil, Jonathan L. Heald & Yasmin Thanavala. (2010) Transgenic Plant-Based Oral Vaccines. Immunological Investigations 39:4-5, pages 468-482.
Read now
Read now
Ali M Harandi, Gwyn Davies & Ole F Olesen. (2009) Vaccine adjuvants: scientific challenges and strategic initiatives. Expert Review of Vaccines 8:3, pages 293-298.
Read now
Read now
Pramod K Giri & Gopal K Khuller. (2008) Is intranasal vaccination a feasible solution for tuberculosis?. Expert Review of Vaccines 7:9, pages 1341-1356.
Read now
Read now
Dorothea Sesardic, Sjoerd Rijpkema & Brijesh Prakash Patel. (2007) New adjuvants: EU regulatory developments. Expert Review of Vaccines 6:5, pages 849-861.
Read now
Read now
Gregory M Glenn, David C Flyer, Larry R Ellingsworth, Sarah A Frech, David M Frerichs, Robert C Seid & Jianmei Yu. (2007) Transcutaneous immunization with heat-labile enterotoxin: development of a needle-free vaccine patch. Expert Review of Vaccines 6:5, pages 809-819.
Read now
Read now
T Mark Doherty, Jes Dietrich & Rolf Billeskov. (2007) Tuberculosis subunit vaccines: from basic science to clinical testing. Expert Opinion on Biological Therapy 7:10, pages 1539-1549.
Read now
Read now
Cara K Fraser, Kerrilyn R Diener, Michael P Brown & John D Hayball. (2007) Improving vaccines by incorporating immunological coadjuvants. Expert Review of Vaccines 6:4, pages 559-578.
Read now
Read now
Dongmei Lu & Anthony J Hickey. (2007) Pulmonary vaccine delivery. Expert Review of Vaccines 6:2, pages 213-226.
Read now
Read now
Fausto Titti, Aurelio Cafaro, Flavia Ferrantelli, Antonella Tripiciano, Sonia Moretti, Antonella Caputo, Riccardo Gavioli, Fabrizio Ensoli, Marjorie Robert-Guroff, Susan Barnett & Barbara Ensoli. (2007) Problems and emerging approaches in HIV/AIDS vaccine development. Expert Opinion on Emerging Drugs 12:1, pages 23-48.
Read now
Read now
Ed C Lavelle & D T O’Hagan. (2006) Delivery systems and adjuvants for oral vaccines. Expert Opinion on Drug Delivery 3:6, pages 747-762.
Read now
Read now
Michael Vajdy & Manmohan Singh. (2006) Intranasal delivery of vaccines against HIV. Expert Opinion on Drug Delivery 3:2, pages 247-259.
Read now
Read now
Barbara C. Baudner, J. Coos Verhoef, Marzia M. Giuliani, Samuele Peppoloni, Rino Rappuoli, Giuseppe Del Giudice & Hans E. Junginger. (2005) Protective immune responses to meningococcal C conjugate vaccine after intranasal immunization of mice with the LTK63 mutant plus chitosan or trimethyl chitosan chloride as novel delivery platform. Journal of Drug Targeting 13:8-9, pages 489-498.
Read now
Read now
Charalambos D Partidos. (2003) Delivering vaccines into the skin without needles and syringes. Expert Review of Vaccines 2:6, pages 753-761.
Read now
Read now
Articles from other publishers (65)
Moein Masjedi, Talieh Montahaei, Zeinab Sharafi & Atefeh Jalali. (2022) Pulmonary vaccine delivery: An emerging strategy for vaccination and immunotherapy. Journal of Drug Delivery Science and Technology 69, pages 103184.
Crossref
Crossref
Shruthishree D. Padiyappa, Hemavathi Avalappa, Madhusudana Somegowda, Shankarappa Sridhara, Yeldur P. Venkatesh, Bettadatunga T. Prabhakar, Siddanakoppalu N. Pramod, Mona S. Almujaydil, Shadi Shokralla, Ashraf M. M. Abdelbacki, Hosam O. Elansary, Ahmed M. El-Sabrout & Eman A. Mahmoud. (2022) Immunoadjuvant and Humoral Immune Responses of Garlic (Allium sativum L.) Lectins upon Systemic and Mucosal Administration in BALB/c Mice. Molecules 27:4, pages 1375.
Crossref
Crossref
David I. Bernstein, Marcela F. Pasetti, Rebecca Brady, Amanda D. Buskirk, Rezwanul Wahid, Michelle Dickey, Mitchell Cohen, Holly Baughman, Jill El-Khorazaty, Nicole Maier, Marcelo B. Sztein, Shahida Baqar & A. Louis Bourgeois. (2019) A Phase 1 dose escalating study of double mutant heat-labile toxin LTR192G/L211A (dmLT) from Enterotoxigenic Escherichia coli (ETEC) by sublingual or oral immunization. Vaccine 37:4, pages 602-611.
Crossref
Crossref
Yu-Li Lin, Pei-Yun Cheng, Chiao-Li Chin, Li-Min Huang, Shr-Yu Lin & Bor-Luen Chiang. (2018) Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine. Vaccine 36:29, pages 4331-4338.
Crossref
Crossref
Natalie E. Nieuwenhuizen & Stefan H. E. Kaufmann. (2018) Next-Generation Vaccines Based on Bacille Calmette–Guérin. Frontiers in Immunology 9.
Crossref
Crossref
Byoung-Shik Shim, In Su Cheon, Eugene Lee, Sung-Moo Park, Youngjoo Choi, Dae-Im Jung, Eunji Yang, Jung-ah Choi, June Young Chun, Jae-Ouk Kim, Cheol-Heui Yun, Cecil Czerkinsky & Man Ki Song. (2018) Development of Safe and Non-Self-Immunogenic Mucosal Adjuvant by Recombinant Fusion of Cholera Toxin A1 Subunit with Protein Transduction Domain. Journal of Immunology Research 2018, pages 1-11.
Crossref
Crossref
Eita Sasaki, Madoka Kuramitsu, Haruka Momose, Kouji Kobiyama, Taiki Aoshi, Hiroshi Yamada, Ken J. Ishii, Takuo Mizukami & Isao Hamaguchi. (2017) A novel vaccinological evaluation of intranasal vaccine and adjuvant safety for preclinical tests. Vaccine 35:5, pages 821-830.
Crossref
Crossref
Atul Srivastava, Devegowda Vishakante Gowda, SubbaRao V. Madhunapantula, Chetan G. Shinde & Meenakshi Iyer. (2015) Mucosal vaccines: a paradigm shift in the development of mucosal adjuvants and delivery vehicles. APMIS 123:4, pages 275-288.
Crossref
Crossref
Xiuyu Xu, Hong Wang, Yusi Liu, Yiping Wang, Lingbing Zeng, Kaifeng Wu, Jianmin Wang, Feng Ma, Wenchun Xu, Yibing Yin & Xuemei Zhang. (2015) Mucosal Immunization with the Live Attenuated Vaccine SPY1 Induces Humoral and Th2-Th17-Regulatory T Cell Cellular Immunity and Protects against Pneumococcal Infection. Infection and Immunity 83:1, pages 90-100.
Crossref
Crossref
Alessandra Borsetti, Flavia Ferrantelli, Maria T. Maggiorella, Leonardo Sernicola, Stefania Bellino, Alessandra Gallinaro, Stefania Farcomeni, Edward T. Mee, Nicola J. Rose, Aurelio Cafaro, Fausto Titti & Barbara Ensoli. (2014) Effect of MHC Haplotype on Immune Response upon Experimental SHIVSF162P4cy Infection of Mauritian Cynomolgus Macaques. PLoS ONE 9:4, pages e93235.
Crossref
Crossref
Yusi Liu, Hong Wang, Shuai Zhang, Lingbin Zeng, Xiuyu Xu, Kaifeng Wu, Wei Wang, Nanlin Yin, Zhixin Song, Xuemei Zhang & Yibing Yin. (2014) Mucosal Immunization with Recombinant Fusion Protein DnaJ-ΔA146Ply Enhances Cross-Protective Immunity against Streptococcus pneumoniae Infection in Mice via Interleukin 17A. Infection and Immunity 82:4, pages 1666-1675.
Crossref
Crossref
Carlos Gamazo & Juan M. Irache. 2014. Molecular Vaccines. Molecular Vaccines
603
622
.
Bruce G. Weniger & Mark J. Papania. 2013. Vaccines. Vaccines
1200
1231
.
Stefania P. Bjarnarson, Brenda C. Adarna, Hreinn Benonisson, Giuseppe Del Giudice & Ingileif Jonsdottir. (2012) The Adjuvant LT-K63 Can Restore Delayed Maturation of Follicular Dendritic Cells and Poor Persistence of Both Protein- and Polysaccharide-Specific Antibody-Secreting Cells in Neonatal Mice. The Journal of Immunology 189:3, pages 1265-1273.
Crossref
Crossref
Carlos Gamazo & Juan M. Irache*. 2012. Nanostructured Biomaterials for Overcoming Biological Barriers. Nanostructured Biomaterials for Overcoming Biological Barriers
91
113
.
A. Borsetti, M. T. Maggiorella, L. Sernicola, S. Bellino, F. Ferrantelli, R. Belli, D. Fulgenzi, E. T. Mee, N. J. Rose, A. Cafaro, B. Ensoli & F. Titti. (2012)
Influence of MHC class I and II haplotypes on the experimental infection of Mauritian cynomolgus macaques with SHIV
SF162P4cy
. Tissue Antigens 80:1, pages 36-45.
Crossref
Crossref
Bert Devriendt, Bruno G. De Geest, Bruno M. Goddeeris & Eric Cox. (2012) Crossing the barrier: Targeting epithelial receptors for enhanced oral vaccine delivery. Journal of Controlled Release 160:3, pages 431-439.
Crossref
Crossref
Rino Rappuoli & Emiliano Chiarot. 2005. Encyclopedia of Life Sciences. Encyclopedia of Life Sciences.
MR Popoff. (2011) Multifaceted interactions of bacterial toxins with the gastrointestinal mucosa. Future Microbiology 6:7, pages 763-797.
Crossref
Crossref
Corinna F. Brereton, Caroline E. Sutton, Pádraig J. Ross, Yoichiro Iwakura, Mariagrazia Pizza, Rino Rappuoli, Ed C. Lavelle & Kingston H. G. Mills. (2011)
Escherichia coli
Heat-Labile Enterotoxin Promotes Protective Th17 Responses against Infection by Driving Innate IL-1 and IL-23 Production
. The Journal of Immunology 186:10, pages 5896-5906.
Crossref
Crossref
Flavia Ferrantelli, Maria Teresa Maggiorella, Ilaria Schiavoni, Leonardo Sernicola, Erika Olivieri, Stefania Farcomeni, Maria Rosaria Pavone-Cossut, Sonia Moretti, Roberto Belli, Barbara Collacchi, Indresh K. Srivastava, Fausto Titti, Aurelio Cafaro, Susan W. Barnett & Barbara Ensoli. (2011) A combination HIV vaccine based on Tat and Env proteins was immunogenic and protected macaques from mucosal SHIV challenge in a pilot study. Vaccine 29:16, pages 2918-2932.
Crossref
Crossref
Yu Fang, Lisa Larsson, Johan Mattsson, Nils Lycke & Zou Xiang. (2010) Mast Cells Contribute to the Mucosal Adjuvant Effect of CTA1–DD after IgG-Complex Formation. The Journal of Immunology 185:5, pages 2935-2941.
Crossref
Crossref
Christelle Basset, Fatou Thiam, Cyrille Di Martino, John Holton, John D. Clements & Evelyne Kohli. (2010) Cholera-Like Enterotoxins and Regulatory T cells. Toxins 2:7, pages 1774-1795.
Crossref
Crossref
Oludare Odumosu, Dequina Nicholas, Hiroshi Yano & William Langridge. (2010) AB Toxins: A Paradigm Switch from Deadly to Desirable. Toxins 2:7, pages 1612-1645.
Crossref
Crossref
Donatella R.M. Negri, Antonella Riccomi, Dora Pinto, Silvia Vendetti, Alessandra Rossi, Rosella Cicconi, Paolo Ruggiero, Giuseppe Del Giudice & Maria Teresa De Magistris. (2010) Persistence of mucosal and systemic immune responses following sublingual immunization. Vaccine 28:25, pages 4175-4180.
Crossref
Crossref
Charalambos D. Partidos. 2010. Topley & Wilson's Microbiology and Microbial Infections. Topley & Wilson's Microbiology and Microbial Infections.
Esther Tamayo, Jorge Postigo, Jovanna González, Maigualida Fernández‐Rey, Marcos Iglesias, Inés Santiuste, Carlo Riccardi, Rino Rappuoli, Giuseppe Del Giudice, Ramón Merino & Jesús Merino. (2010)
GITR contributes to the systemic adjuvanticity of the
Escherichia coli
heat‐labile enterotoxin
. European Journal of Immunology 40:3, pages 754-763.
Crossref
Crossref
David J. M. Lewis, Zhiming Huo, Susan Barnett, Ingrid Kromann, Rafaela Giemza, Eva Galiza, Maria Woodrow, Birgit Thierry-Carstensen, Peter Andersen, Deborah Novicki, Giuseppe Del Giudice & Rino Rappuoli. (2009) Transient Facial Nerve Paralysis (Bell's Palsy) following Intranasal Delivery of a Genetically Detoxified Mutant of Escherichia coli Heat Labile Toxin. PLoS ONE 4:9, pages e6999.
Crossref
Crossref
Claudia Gianfaldoni, Silvia Maccari, Laura Pancotto, Giacomo Rossi, Markus Hilleringmann, Werner Pansegrau, Antonia Sinisi, Monica Moschioni, Vega Masignani, Rino Rappuoli, Giuseppe Del Giudice & Paolo Ruggiero. (2009)
Sortase A Confers Protection against
Streptococcus pneumoniae
in Mice
. Infection and Immunity 77:7, pages 2957-2961.
Crossref
Crossref
Shuang Liang, Kavita B. Hosur, Hesham F. Nawar, Michael W. Russell, Terry D. Connell & George Hajishengallis. (2009) In vivo and in vitro adjuvant activities of the B subunit of Type IIb heat-labile enterotoxin (LT-IIb-B5) from Escherichia coli. Vaccine 27:32, pages 4302-4308.
Crossref
Crossref
Fu Shi Quan, Dae-Goon Yoo, Jae-Min Song, John D. Clements, Richard W. Compans & Sang-Moo Kang. (2009) Kinetics of Immune Responses to Influenza Virus-Like Particles and Dose-Dependence of Protection with a Single Vaccination. Journal of Virology 83:9, pages 4489-4497.
Crossref
Crossref
Fengmin Zhou, Amanda Goodsell, Yasushi Uematsu & Michael Vajdy. (2009) Prolonged Protection against Intranasal Challenge with Influenza Virus following Systemic Immunization or Combinations of Mucosal and Systemic Immunizations with a Heat-Labile Toxin Mutant. Clinical and Vaccine Immunology 16:4, pages 471-478.
Crossref
Crossref
Sameer Sharma, T.K.S. Mukkur, Heather A.E. Benson & Yan Chen. (2009) Pharmaceutical Aspects of Intranasal Delivery of Vaccines Using Particulate Systems. Journal of Pharmaceutical Sciences 98:3, pages 812-843.
Crossref
Crossref
Siggeir F. Brynjolfsson, Stefania P. Bjarnarson, Elena Mori, Giuseppe Del Giudice & Ingileif Jonsdottir. (2008) Neonatal immune response and serum bactericidal activity induced by a meningococcal conjugate vaccine is enhanced by LT-K63 and CpG2006. Vaccine 26:35, pages 4557-4562.
Crossref
Crossref
Chao Wu, Yun Shi, Hong Guo, Wei-Ying Zou, Gang Guo, Qing-Hua Xie, Xu-Hu Mao, Wen-De Tong & Quan-Ming Zou. (2008) Protection Against Helicobacter pylori Infection in Mongolian Gerbil by Intragastric or Intramuscular Administration of H. pylori Multicomponent Vaccine. Helicobacter 13:3, pages 191-199.
Crossref
Crossref
Antonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, Rebecca Voltan, Riccardo Gavioli, Indresh K. Srivastava, Susan W. Barnett, Aurelio Cafaro & Barbara Ensoli. (2008) Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 ΔV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxin. Vaccine 26:9, pages 1214-1227.
Crossref
Crossref
Bruce G. Weniger & Mark J. Papania. 2008. Vaccines. Vaccines
1357
1392
.
Frederick R. Vogel & Stanley L. Hem. 2008. Vaccines. Vaccines
59
71
.
Michael Vajdy. 2008. Immunity Against Mucosal Pathogens. Immunity Against Mucosal Pathogens
415
430
.
Barbara Rath, Thomas Linder, David Cornblath, Michael Hudson, Rohini Fernandopulle, Katharina Hartmann, Ulrich Heininger, Hector Izurieta, Leslie Killion, Pangiotis Kokotis, James Oleske, Michael Vajdy & Virginia Wong. (2007) “All that palsies is not Bell's [1]”—The need to define Bell's palsy as an adverse event following immunization. Vaccine 26:1, pages 1-14.
Crossref
Crossref
Elaine Tritto, Alessandro Muzzi, Isabella Pesce, Elisabetta Monaci, Sandra Nuti, Grazia Galli, Andreas Wack, Rino Rappuoli, Tracy Hussell & Ennio De Gregorio. (2007) The Acquired Immune Response to the Mucosal Adjuvant LTK63 Imprints the Mouse Lung with a Protective Signature. The Journal of Immunology 179:8, pages 5346-5357.
Crossref
Crossref
T. A. Olafsdottir, S. G. Hannesdottir, G. D. Giudice, E. Trannoy & I. Jonsdottir. (2007) Effects of LT-K63 and CpG2006 on Phenotype and Function of Murine Neonatal Lymphoid Cells. Scandinavian Journal of Immunology 66:4, pages 426-434.
Crossref
Crossref
Michael Vajdy, Barbara Baudner, Giuseppe Del Giudice & Derek O’Hagan. (2007) A vaccination strategy to enhance mucosal and systemic antibody and T cell responses against influenza. Clinical Immunology 123:2, pages 166-175.
Crossref
Crossref
Naoya Ohmori, Takeshi Goto & Shuji Sato. (2007) Transdermal vaccine delivery system(TVDSs). Drug Delivery System 22:4, pages 468-475.
Crossref
Crossref
Jun Kunisawa, Jerry R. McGhee & Hiroshi Kiyono. 2007. Mucosal Immune Defense: Immunoglobulin A. Mucosal Immune Defense: Immunoglobulin A
345
389
.
Michael G. Jobling & Randall K. Holmes. (2006) Heat-Labile Enterotoxins. EcoSal Plus 2:1.
Crossref
Crossref
Sven Baumann, Ali Nasser Eddine & Stefan HE Kaufmann. (2006) Progress in tuberculosis vaccine development. Current Opinion in Immunology 18:4, pages 438-448.
Crossref
Crossref
Ali Nasser Eddine, Sven Baumann & Stefan H.E. Kaufmann. (2006) New tuberculosis vaccines approaching clinical trial – An overview. Drug Discovery Today: Therapeutic Strategies 3:2, pages 113-119.
Crossref
Crossref
Iain Stephenson, Maria C. Zambon, Anna Rudin, Anthony Colegate, Audino Podda, Roberto Bugarini, Giusseppe del Giudice, Ada Minutello, Susan Bonnington, Jan Holmgren, Kingston H. G. Mills & Karl G. Nicholson. (2006)
Phase I Evaluation of Intranasal Trivalent Inactivated Influenza Vaccine with Nontoxigenic
Escherichia coli
Enterotoxin and Novel Biovector as Mucosal Adjuvants, Using Adult Volunteers
. Journal of Virology 80:10, pages 4962-4970.
Crossref
Crossref
Jakub K. Simon & Robert Edelman. 2006. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
319
342
.
Debbie Drane & Martin J. Pearse. 2006. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
191
215
.
Derek T. O'Hagan. 2006. Immunopotentiators in Modern Vaccines. Immunopotentiators in Modern Vaccines
123
147
.
G. M. Glenn & R. T. Kenney. 2006. Mass Vaccination: Global Aspects — Progress and Obstacles. Mass Vaccination: Global Aspects — Progress and Obstacles
247
268
.
T. Mark Doherty & Peter Andersen. (2005) Vaccines for Tuberculosis: Novel Concepts and Recent Progress. Clinical Microbiology Reviews 18:4, pages 687-702.
Crossref
Crossref
Richard I. Walker. (2005) Considerations for development of whole cell bacterial vaccines to prevent diarrheal diseases in children in developing countries. Vaccine 23:26, pages 3369-3385.
Crossref
Crossref
Peter Andersen & T. Mark Doherty. (2005) TB subunit vaccines—putting the pieces together. Microbes and Infection 7:5-6, pages 911-921.
Crossref
Crossref
Sterghios A. Moschos, Vincent W. Bramwell, Satyanarayna Somavarapu & H. Oya Alpar. (2005) Comparative immunomodulatory properties of a chitosan-MDP adjuvant combination following intranasal or intramuscular immunisation. Vaccine 23:16, pages 1923-1930.
Crossref
Crossref
Qiang FENG, Jun YANG, Ping LUO, Wei-Jun ZHANG & Quan-Ming ZOU. (2005) LT(K63/R72), a New Mutant of Escherichia coli Heat-labile Enterotoxin, Exhibits Characteristics More Similar to LT(K63) than LT(R72). Acta Biochimica et Biophysica Sinica 37:2, pages 126-132.
Crossref
Crossref
Muneki Hotomi, Yorihiko Ikeda, Masaki Suzumoto, Kazuma Yamauchi, Bruce A. Green, Gary Zlotnick, Dewan S. Billal, Jun Shimada, Keiji Fujihara & Noboru Yamanaka. (2005) A recombinant P4 protein of Haemophilus influenzae induces specific immune responses biologically active against nasopharyngeal colonization in mice after intranasal immunization. Vaccine 23:10, pages 1294-1300.
Crossref
Crossref
SA Moschos, VW Bramwell, S Somavarapu & HO Alpar. (2004) Adjuvant synergy: The effects of nasal coadministration of adjuvants. Immunology & Cell Biology 82:6, pages 628-637.
Crossref
Crossref
Michael VajdyManmohan SinghJina KazzazElawati SoenawanMildred UgozzoliFengmin ZhouIndresh SrivastavaQian BinSusan BarnettJohn DonnellyPaul LuciwLou AdamsonDavid MontefioriDerek T. O’hagan. (2004) Mucosal and Systemic Anti-HIV Responses in Rhesus Macaques following Combinations of Intranasal and Parenteral Immunizations. AIDS Research and Human Retroviruses 20:11, pages 1269-1281.
Crossref
Crossref
Frances Bowe, Ed C. Lavelle, Edel A. McNeela, Christine Hale, Simon Clare, Beatrice Arico, Marzia M. Giuliani, Aaron Rae, Alan Huett, Rino Rappuoli, Gordon Dougan & Kingston H. G. Mills. (2004)
Mucosal Vaccination against Serogroup B Meningococci: Induction of Bactericidal Antibodies and Cellular Immunity following Intranasal Immunization with NadA of
Neisseria meningitidis
and Mutants of
Escherichia coli
Heat-Labile Enterotoxin
. Infection and Immunity 72:7, pages 4052-4060.
Crossref
Crossref
T. Mark Doherty. (2004) New vaccines against tuberculosis. Tropical Medicine and International Health 9:7, pages 818-826.
Crossref
Crossref
Gregory M Glenn, Richard T Kenney, Scott A Hammond & Larry R Ellingsworth. (2003) Transcutaneous immunization and immunostimulant strategies. Immunology and Allergy Clinics of North America 23:4, pages 787-813.
Crossref
Crossref
Derek T. O'Hagan & Nicholas M. Valiante. (2003) Recent advances in the discovery and delivery of vaccine adjuvants. Nature Reviews Drug Discovery 2:9, pages 727-735.
Crossref
Crossref